Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Unknown 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Solid Tumors 433Advanced Solid Tumor 352Solid Tumor 305Solid Tumors 246Mesothelioma 115Solid Tumor, Adult 76Mesothelioma, Malignant 72Carcinoma, Non-Small-Cell Lung 66Ovarian Neoplasms 47Melanoma 42Carcinoma, Renal Cell 37Colorectal Neoplasms 34Advanced or Metastatic Solid Tumors 32Uterine Cervical Neoplasms 31Stomach Neoplasms 31Solid Tumours 31Esophageal Neoplasms 30Neoplasms 27Pancreatic Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Breast Neoplasms 25Advanced Malignant Solid Tumors 25Triple Negative Breast Neoplasms 24Lung Neoplasms 24Small Cell Lung Carcinoma 23Advanced Solid Tumours 23Sarcoma 21Neoplasm Metastasis 21Advanced Malignant Solid Tumor 21Locally Advanced or Metastatic Solid Tumors 20

Interventions

nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Advanced and/or Metastatic Solid Tumours × Other solid neoplasm × Clear all
NCT05836623 2024-02-28

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Crescendo Biologics Ltd.

Phase 1 Unknown
5 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT04839991 2023-11-18

POTENTIA

Crescendo Biologics Ltd.

Phase 1 Unknown
70 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡